An autopsy case of TAFRO syndrome with membranoproliferative glomerulonephritis-like lesions.


Journal

CEN case reports
ISSN: 2192-4449
Titre abrégé: CEN Case Rep
Pays: Japan
ID NLM: 101636244

Informations de publication

Date de publication:
02 2019
Historique:
received: 15 03 2018
accepted: 09 09 2018
pubmed: 24 9 2018
medline: 6 8 2019
entrez: 24 9 2018
Statut: ppublish

Résumé

TAFRO syndrome (thrombocytopenia, anasarca, myelofibrosis, renal dysfunction, and organomegaly) is an atypical manifestation of multicentric Castleman's disease. Although overproduction of interleukin-6, vascular endothelial growth factor, and other cytokines may partially explain the pathophysiology of this rare syndrome, the precise mechanisms underlying the renal dysfunction associated with the condition remain unclear. Here, we describe a case of a 69-year-old male with TAFRO syndrome. He was treated with immunosuppressive agents and his renal function improved. Tapering of immunosuppressive agents resulted in a deterioration of renal function and an elevation of C-reactive protein. After 20 months of treatment, the patient died from tuberculous peritonitis and gastrointestinal bleeding. An autopsy revealed miliary tuberculosis, mediastinal lymphadenopathy, and gastric ulcers. Renal histopathology showed a membranoproliferative glomerulonephritis-like appearance. Almost all glomeruli showed lobular formations with mesangial proliferation and duplication of glomerular capillary walls on light microscopy. Immunofluorescence showed deposition of C1q and IgM along the glomerular capillary walls. Electron microscopy showed mesangial expansion and widening of the subendothelial space with a large number of electron-dense deposits. The glomerular lesions might be characteristic of TAFRO syndrome, and were regarded as the main cause of the patient's renal dysfunction.

Identifiants

pubmed: 30244358
doi: 10.1007/s13730-018-0363-9
pii: 10.1007/s13730-018-0363-9
pmc: PMC6361076
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Pagination

48-54

Références

Nephrol Dial Transplant. 1999 Oct;14(10):2370-8
pubmed: 10528660
Rinsho Ketsueki. 2010 May;51(5):320-5
pubmed: 20534952
Nephrol Dial Transplant. 2012 Oct;27 Suppl 3:iii119-25
pubmed: 21602182
J Clin Exp Hematop. 2013;53(1):57-61
pubmed: 23801135
J Clin Exp Hematop. 2013;53(1):63-8
pubmed: 23801136
J Clin Exp Hematop. 2013;53(1):69-77
pubmed: 23801137
J Clin Exp Hematop. 2013;53(1):79-85
pubmed: 23801138
J Clin Exp Hematop. 2013;53(1):87-93
pubmed: 23801139
J Clin Exp Hematop. 2013;53(1):95-9
pubmed: 23801140
Intern Med. 2013;52(13):1503-7
pubmed: 23812199
Rinsho Ketsueki. 2014 Mar;55(3):350-5
pubmed: 24681940
Tohoku J Exp Med. 2015;236(4):289-95
pubmed: 26250536
Intern Med. 2016;55(2):185-90
pubmed: 26781021
Am J Hematol. 2016 Feb;91(2):220-6
pubmed: 26805758
Int J Hematol. 2016 Jun;103(6):718-23
pubmed: 26980221
Int J Hematol. 2016 Jun;103(6):686-92
pubmed: 27084250
Am J Med. 2016 Sep;129(9):938-41
pubmed: 27267287
Medicine (Baltimore). 2017 Mar;96(13):e6271
pubmed: 28353560
Medicine (Baltimore). 2017 Oct;96(40):e8216
pubmed: 28984775
Hematol Oncol Clin North Am. 2018 Feb;32(1):107-118
pubmed: 29157612
Hematol Oncol Clin North Am. 2018 Feb;32(1):119-139
pubmed: 29157614
Hematol Oncol Clin North Am. 2018 Feb;32(1):53-64
pubmed: 29157619
Hum Pathol. 2018 Dec;82:258-263
pubmed: 29626596
CEN Case Rep. 2018 Nov;7(2):243-247
pubmed: 29766467
Medicine (Baltimore). 2018 Jun;97(24):e11057
pubmed: 29901607
Nephrol Dial Transplant. 1998 Jun;13(6):1556-8
pubmed: 9641194

Auteurs

Keiko Hashimoto (K)

Department of Nephrology, Kitasato University School of Medicine, Sagamihara, Japan.

Takashi Sano (T)

Department of Nephrology, Kitasato University School of Medicine, Sagamihara, Japan. taksano@med.kitasato-u.ac.jp.

Yukari Honma (Y)

Department of Nephrology, Kitasato University School of Medicine, Sagamihara, Japan.

Maoko Ida (M)

Department of Nephrology, Kitasato University School of Medicine, Sagamihara, Japan.

Hiroshi Tominaga (H)

Department of Nephrology, Kitasato University School of Medicine, Sagamihara, Japan.

Aya Sawada (A)

Department of Nephrology, Kitasato University School of Medicine, Sagamihara, Japan.

Tetsuya Abe (T)

Department of Nephrology, Kitasato University School of Medicine, Sagamihara, Japan.

Haruka Takahashi (H)

Department of Nephrology, Kitasato University School of Medicine, Sagamihara, Japan.

Yoshitaka Shimada (Y)

Department of Nephrology, Kitasato University School of Medicine, Sagamihara, Japan.

Takanori Masaki (T)

Department of Nephrology, Kitasato University School of Medicine, Sagamihara, Japan.

Mariko Kamata (M)

Department of Nephrology, Kitasato University School of Medicine, Sagamihara, Japan.

Shokichi Naito (S)

Department of Nephrology, Kitasato University School of Medicine, Sagamihara, Japan.

Togo Aoyama (T)

Department of Nephrology, Kitasato University School of Medicine, Sagamihara, Japan.

Yasuo Takeuchi (Y)

Department of Nephrology, Kitasato University School of Medicine, Sagamihara, Japan.

Masashi Akiya (M)

Department of Pathology, Kitasato University School of Medicine, Sagamihara, Japan.

Madoka Inukai (M)

Department of Pathology, Kitasato University School of Medicine, Sagamihara, Japan.

Norihiro Nakata (N)

Department of Pathology, Kitasato University School of Medicine, Sagamihara, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH